- Home
- XHR vs JANX Comparison
XHR vs JANX Comparison
Compare XHR & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XHR
- JANX
- Stock Information
- Founded
- XHR 2007
- JANX 2017
- Country
- XHR United States
- JANX United States
- Employees
- XHR N/A
- JANX N/A
- Industry
- XHR Real Estate Investment Trusts
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- XHR Real Estate
- JANX Health Care
- Exchange
- XHR Nasdaq
- JANX Nasdaq
- Market Cap
- XHR 1.5B
- JANX 1.6B
- IPO Year
- XHR N/A
- JANX 2021
- Fundamental
- Price
- XHR $12.68
- JANX $23.10
- Analyst Decision
- XHR Hold
- JANX Strong Buy
- Analyst Count
- XHR 5
- JANX 7
- Target Price
- XHR $13.50
- JANX $94.29
- AVG Volume (30 Days)
- XHR 899.0K
- JANX 606.4K
- Earning Date
- XHR 08-01-2025
- JANX 08-06-2025
- Dividend Yield
- XHR 4.42%
- JANX N/A
- EPS Growth
- XHR 16.62
- JANX N/A
- EPS
- XHR 0.22
- JANX N/A
- Revenue
- XHR $1,060,486,000.00
- JANX $9,336,000.00
- Revenue This Year
- XHR $3.27
- JANX N/A
- Revenue Next Year
- XHR $3.26
- JANX $1,470.82
- P/E Ratio
- XHR $57.92
- JANX N/A
- Revenue Growth
- XHR 3.57
- JANX 28.12
- 52 Week Low
- XHR $8.55
- JANX $22.48
- 52 Week High
- XHR $16.50
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- XHR 61.85
- JANX 40.54
- Support Level
- XHR $12.13
- JANX $22.56
- Resistance Level
- XHR $12.67
- JANX $24.19
- Average True Range (ATR)
- XHR 0.27
- JANX 1.33
- MACD
- XHR 0.01
- JANX -0.05
- Stochastic Oscillator
- XHR 97.71
- JANX 12.55
About XHR Xenia Hotels & Resorts Inc.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The room segment contributes to the vast majority of the firm's total revenue. The firm's customer groups include transient business, group business, and contract business.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.